A randomized, double-blind controlled study of Kuoxinfang in the treatment on Deficiency of both Qi and Yin combined blood stasis with dilated cardiomyopathy

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Treatment group:Kuoxinfang granules combined with conventional western medicine;Control group:Kuoxinfang granule placebo combined with conventional western medicine; CONDITION: Dilated cardiomyopathy PRIMARY OUTCOME: Clinical efficacy and improvement of cardiac function; SECONDARY OUTCOME: Evaluation of the efficacy of TCM syndrome;Cardiac Doppler ultrasound; INCLUSION CRITERIA: 1. Meet the diagnostic criteria of Western medicine and traditional Chinese medicine for dilated cardiomyopathy; 2. NYHA was grade II‐IV; 3. Aged 45‐80 years; 4. Left ventricle Left ventricular ejection fraction (LVEF) <=45%; 5. Agree to participate in clinical trial observation, sign informed consent and indicate the date.
Epistemonikos ID: 5b1d2b371c5ab4f0090c92ca0e9521a5725c9799
First added on: Feb 20, 2024